EUVIMEDEUVIMED entdecken
Crossref

Prices, availability and affordability of selected essential medicines for chronic diseases in Türkiye

Gökçen Özler, Oğuz Işik

Eastern Mediterranean Health Journal · 2023

DOI: 10.26719/emhj.23.117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eastern Mediterranean Health Journal, 2023. Verfasst von Gökçen Özler und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management, Faculty of Health Sciences, Ankara University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Health Services Accessibility, Drugs, Essential. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fair access to essential medicines is a significant parameter in fulfilling the right to basic health.

Aim

We investigated the availability, prices and affordability of essential medicines for chronic diseases in Ankara, Türkiye.

Methods

We used the procedures outlined in the WHO and Health Action International guidelines for measuring prices, availability, affordability, and price components of medicines. The sample consisted of 334 (14%) of the 2354 pharmacies in Ankara, and 24 essential medicines for cardiovascular diseases, diabetes, chronic respiratory diseases, and palliative care, adopted from the WHO Model List of Essential Medicines (2021). We collected the data in 2021 using a questionnaire administered through face-to-face survey and analysed the data using SPSS version 22.

Results

The findings showed that 15 medicines (62.5% of the selected medicines) met the 80% availability target set by WHO, while 9 did not. The original medicines were more readily available than the generic ones. Among the original medicines, furosemide (10.11) and acetylsalicylic acid (9.26) had the highest median price ratios. The generic medicines seemed to be more affordable than original medicines. Glibenclamide, budesonide, gliclazide, and diazepam had low availability and were sold at higher prices than their international reference prices.

Conclusion

This research highlights priority areas of action to improve access to affordable medicines for chronic diseases in Ankara, Türkiye.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health Services AccessibilityDrugs, EssentialHumansTurkeyPrivate SectorCosts and Cost AnalysisDrugs, GenericChronic Disease

Stichwörter der Autor:innen

Türkiyeaffordabilityavailabilitychronic diseaseessential medicinesmedicines policy

Substanzen

Drugs, EssentialDrugs, Generic

Autor:innen und Institutionen

  • Department of Health Management, Faculty of Health Sciences, Ankara University, Ankara, Türkiye.
  • Department of Health Management, Faculty of Economics and Administrative Sciences, Hacettepe University, Ankara, Türkiye.

Zitieren

APA

Özler, G., & Işik, O. (2023). Prices, availability and affordability of selected essential medicines for chronic diseases in Türkiye. Eastern Mediterranean Health Journal. https://doi.org/10.26719/emhj.23.117

Vancouver

Özler G, Işik O. Prices, availability and affordability of selected essential medicines for chronic diseases in Türkiye. Eastern Mediterranean Health Journal. 2023. doi:10.26719/emhj.23.117

BibTeX
@article{zler2023,
  author = {Özler, Gökçen and Işik, Oğuz},
  title = {Prices, availability and affordability of selected essential medicines for chronic diseases in Türkiye},
  journal = {Eastern Mediterranean Health Journal},
  year = {2023},
  doi = {10.26719/emhj.23.117}
}
Kostenlos starten →